Two weeks before the 2024 presidential election, Robert F. Kennedy Jr. tweeted that “the FDA’s war on public health is about to end.” He then listed a host of treatments, all of which he claimed had been “aggressively suppressed” by a corrupt Big Pharma system.

Two Ps – psychedelics and peptides – featured on that list of treatments, one more familiar than the other. You could be forgiven for thinking that peptides are a recent creation but they’re not. They’ve been around for a long time, but they’ve gained huge attention due to Wegovy and Ozempic.

Peptides are natural compounds: short chains of amino acids (the building blocks of proteins) that function as signaling molecules within the body, sending a wide variety of messages to all sorts of tissues, from the skin to muscle and internal organs.

Trump’s presence won’t sway the Supreme Court

The age of the aircraft carrier is over

Will Artemis II fulfill our Space Age dreams?

The global market for peptides is growing rapidly. The regulated market alone is worth $50 billion and is projected to double by the early 2030s. The first major peptide to be synthesized was insulin, which plays a vital role in regulating blood-sugar levels. About eight million people in the US currently take insulin, mostly diabetics, but it is also used as a growth promoter by professional bodybuilders. Peptides such as insulin, Wegovy and Ozempic clearly work. They’ve been fully licensed for human use and their effects are visible for all to see.

But when it comes to the newer peptides – or at least those that have finally escaped obscure........

© The Spectator